CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Metachromatic Leukodystrophy Mld

Metachromatic leukodystrophy (MLD) is a rare genetic disorder that affects the nervous system and leads to the destruction of the protective covering of nerve fibers called myelin. The disease is caused by a deficiency in the enzyme arylsulfatase A, which is essential for breaking down sulfatides, a type of fat molecule found in myelin. Symptoms of MLD can include muscle weakness, loss of coordination, vision and hearing loss, seizures, and developmental delays.

Entire World
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information

Trademark Disclaimer

WCG’s Clinical Trial Listing Service (CTLS) is an online database of clinical research studies curated from public and proprietary sources.

Any references to third-party entities, companies, brands, trademarks, service marks, or logos are provided solely for informational purposes. Such references do not imply any endorsement, sponsorship, authorization, recommendation, partnership, or other affiliation between WCG and any such third party.